Price is syncing
Reported smart-money activity is still available below.
1 month
-1.9%
price return
Year to date
+2.6%
price return
Recent earnings
0/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
33 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage leans bullish
9 bullish · 21 neutral · 3 bearish
Tone of tracked coverage
Affinity Asset Advisors LLC Has $11.14 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIO
NeutralJul 25Form S-3ASR BridgeBio Pharma Inc For: 24 July By Investing.com
NeutralJul 25BridgeBio Pharma, Inc. Revenue Breakdown – NASDAQ:BBIO
Leans bullishJul 25Bridgebio Pharma Inc Files For Offering Of Up To 24.6 Million Common Shares By Selling Stockholders - SEC Filing
Leans bearishJul 24BridgeBio Pharma Inc (BBIO) Shareholder Structure: Major Shareholders & Institutional Holdings
NeutralJul 24Is FDA’s Encaleret NDA Acceptance Redefining the Investment Case For BridgeBio Pharma (BBIO)?
Leans bullishJul 24Monashee Investment Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
NeutralJul 24BBIO5151039 Bond Profile — Key Metrics
NeutralJul 23Q1 2026 13F
$91.0M
position
AlphaYou
